NMP-7

From Wikipedia, the free encyclopedia
Jump to: navigation, search
NMP-7
NMP-7 structure.png
Systematic (IUPAC) name
(9-pentylcarbazol-3-yl)-piperidin-1-ylmethanone
Clinical data
Legal status
?
Identifiers
CAS number 1358039-07-2
ATC code ?
PubChem CID 46871949
ChemSpider 27470961
Chemical data
Formula C23H28N2O 
Mol. mass 348.480 g/mol

NMP-7 is a drug which acts as both a non-selective agonist of the CB1 and CB2 cannabinoid receptors, and also as a blocker of T-type calcium channels, the target of anticonvulsant drugs such as ethosuximide. NMP-7 has an agonist EC50 of 96.9nM at CB1 and 10.5nM at CB2, and an IC50 of 1.84μM for blocking Cav3.2 T-type calcium channels. In animal studies it produces potent analgesic effects in a variety of different tests.[1]


References[edit]

  1. ^ You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P. Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands. Molecular Pain. 2011 Nov 17;7:89. PMID 22093952